A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. Reda the News Release on the NIH website: NIH clinical trial of investigational vaccine for COVID-19 begins: Study enrolling Seattle-based healthy adult volunteers.
Comments
Post a Comment